At the Center for Engineering and Biotechnology (CIBG) in Camaguey, researcher and urologist Ranfis Rodriguez has administed a vaccine to cancer patients. Fifty-six patients have received the vaccine. Their results show that a there is a decrease in their prostate specific antigen (PSA), but with no (or little) production of testosterone. Another researcher, Jesus Junco, hopes to treat patients with stage 3 and 4 prostate cancer with this vaccine.
In Cuba, about 2,500 men of 60+ years in age developed prostate cancer. Of those, the mortality rate is close to 60%. This vaccine would help many patients.
Would you be willing to take a vaccine if you were diagnosed with prostate cancer?
In Cuba, about 2,500 men of 60+ years in age developed prostate cancer. Of those, the mortality rate is close to 60%. This vaccine would help many patients.
Would you be willing to take a vaccine if you were diagnosed with prostate cancer?
